Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$208M |
| 2 |
Lowe's Companies
LOW
|
+$198M |
| 3 |
American Tower
AMT
|
+$161M |
| 4 |
Lennar Class A
LEN
|
+$150M |
| 5 |
British American Tobacco
BTI
|
+$150M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$208M |
| 2 |
CXO
CONCHO RESOURCES INC.
CXO
|
+$177M |
| 3 |
Crown Castle
CCI
|
+$168M |
| 4 |
Walmart Inc
WMT
|
+$167M |
| 5 |
Entergy
ETR
|
+$157M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 13.75% |
| 2 | Technology | 13.18% |
| 3 | Healthcare | 11.51% |
| 4 | Industrials | 10.45% |
| 5 | Consumer Discretionary | 9.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2176
Greenlight Captial
GLRE
$503M
| $1.96M | ﹤0.01% |
+90,429
| New | +$1.95M |
|
2177
Bank of Marin Bancorp
BMRC
$433M
| $1.95M | ﹤0.01% |
+57,052
| New | +$1.85M |
|
2178
CALL
Masco
MAS
$14.5B
| $1.95M | ﹤0.01% |
+50,000
| New | +$1.88M |
|
|
TGI
2179
DELISTED
Triumph Group
TGI
| $1.95M | ﹤0.01% |
65,391
-564,425
| -90% | -$16.1M |
|
2180
Laureate Education
LAUR
$5.33B
| $1.94M | ﹤0.01% |
+133,626
| New | +$2.09M |
|
|
FSB
2181
DELISTED
Franklin Financial Network, Inc.
FSB
| $1.94M | ﹤0.01% |
54,490
+48,436
| +800% | +$1.71M |
|
2182
PUT
Centene
CNC
$32.4B
| $1.94M | ﹤0.01% |
+40,000
| New | +$1.72M |
|
|
DHC
2183
Diversified Healthcare Trust
DHC
$1.94B
| $1.93M | ﹤0.01% |
98,922
-75,843
| -43% | -$1.48M |
|
2184
PUT
Corcept Therapeutics
CORT
$13.2B
| $1.93M | ﹤0.01% |
+100,000
| New | +$1.49M |
|
2185
Orion
OEC
$345M
| $1.93M | ﹤0.01% |
85,887
+39,194
| +84% | +$840K |
|
2186
WaFd
WAFD
$2.68B
| $1.93M | ﹤0.01% |
57,238
+49,281
| +619% | +$1.6M |
|
|
TOO
2187
DELISTED
Teekay Offshore Partners L.P.
TOO
| $1.92M | ﹤0.01% |
807,657
+782,876
| +3,159% | +$1.95M |
|
2188
Trustmark
TRMK
$2.69B
| $1.91M | ﹤0.01% |
57,629
-63,901
| -53% | -$1.99M |
|
2189
OneSpan
OSPN
$568M
| $1.91M | ﹤0.01% |
+158,254
| New | +$2.03M |
|
|
BKS
2190
DELISTED
Barnes & Noble
BKS
| $1.91M | ﹤0.01% |
250,839
-959,762
| -79% | -$7.16M |
|
|
OA
2191
DELISTED
Orbital ATK, Inc.
OA
| $1.9M | ﹤0.01% |
14,245
-200,876
| -93% | -$22M |
|
|
AGEN
2192
CALL
Agenus
AGEN
$371M
| $1.9M | ﹤0.01% |
21,898
+9,160
| +72% | +$743K |
|
2193
Main Street Capital
MAIN
$5.47B
| $1.9M | ﹤0.01% |
+47,672
| New | +$1.87M |
|
2194
Minerals Technologies
MTX
$2.24B
| $1.9M | ﹤0.01% |
26,817
-23,960
| -47% | -$1.64M |
|
2195
Minerva Neurosciences
NERV
$261M
| $1.89M | ﹤0.01% |
31,128
+23,832
| +327% | +$1.37M |
|
|
ISEE
2196
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $1.88M | ﹤0.01% |
668,234
-98,144
| -13% | -$265K |
|
|
ARAV
2197
DELISTED
Aravive, Inc. Common Stock
ARAV
| $1.88M | ﹤0.01% |
127,639
+102,081
| +399% | +$10.3M |
|
|
TRIB
2198
Trinity Biotech
TRIB
$7.94M
| $1.87M | ﹤0.01% |
2,227
-276
| -11% | -$231K |
|
2199
PUT
Quest Diagnostics
DGX
$26.9B
| $1.87M | ﹤0.01% |
+20,000
| New | +$2.12M |
|
2200
Steris
STE
$23.1B
| $1.87M | ﹤0.01% |
+21,167
| New | +$1.79M |
|
Similar funds
Israel Englander's Q3 2017 Portfolio in Review
As of Q3 2017, Israel Englander held 4,198 positions worth $65.6B, up 17% from $56.1B the previous quarter. Its ten largest holdings account for 7.8% of the portfolio.
Israel Englander deployed $6.37B of net new capital in Q3 2017, opening 794 new positions and adding to 1,441 existing holdings. Its largest new stake was Northern Trust: 1,591,041 shares worth $146M.
By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 12% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Gilead Sciences, an estimated $208M trimmed.
- Israel Englander's largest Q3 2017 buy was Northern Trust: 1,591,041 shares worth $146M.
- Israel Englander added most to Salesforce in Q3 2017, an estimated $208M increase.
- Israel Englander's biggest Q3 2017 reduction was Gilead Sciences, cutting an estimated $208M.
- Israel Englander fully exited CONCHO RESOURCES INC. in Q3 2017, selling an estimated $177M.
- Israel Englander's ten largest holdings make up 7.8% of its $65.6B portfolio in Q3 2017.
- Israel Englander opened 794 new positions and closed 737 in Q3 2017.
- Israel Englander's portfolio value rose 17% quarter-over-quarter to $65.6B.
Based on Millennium Management's 13F filing for Q3 2017, filed 14 Nov 2017.